Navigation Links
Application for Listing of Shire Limited Ordinary Shares
Date:5/22/2008

a)(10) thereof.

"SAFE HARBOR" STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995

Statements included herein that are not historical facts are forward-looking statements. Such forward-looking statements involve a number of risks and uncertainties and are subject to change at any time. In the event such risks or uncertainties materialize, Shire's results could be materially affected. The risks and uncertainties include, but are not limited to, risks associated with: the inherent uncertainty of pharmaceutical research, product development including, but not limited to the successful development of JUVISTA(R) (Human TGF beta 3) and veleglucerase alfa (GA-GCB); manufacturing and commercialization including, but not limited to, the establishment in the market of VYVANSE(TM) (lisdexamfetamine dimesylate) (Attention Deficit and Hyperactivity Disorder ("ADHD")); the impact of competitive products, including, but not limited to, the impact of those on Shire's ADHD franchise; patents, including but not limited to, legal challenges relating to Shire's ADHD franchise; government regulation and approval, including but not limited to the expected product approval date of INTUNIV(TM) (guanfacine extended release) (ADHD); Shire's ability to secure new products for commercialization and/or development; and other risks and uncertainties detailed from time to time in Shire's filings with the Securities and Exchange Commission, including Shire plc's Annual Report on Form 10-K for the year ended December 31, 2007.


'/>"/>
SOURCE Shire Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. European EMEA Acceptance of Marketing Authorization Application Filing for SNT-MC17 in Friedreichs Ataxia by Santhera
2. Barr Confirms Filing an Application With a Paragraph IV Certification for Femcon(R) FE Chewable Oral Contraceptive Product
3. KineMed to Collaborate With Merck KgaA to Validate New Applications for Drug Development Candidates
4. MichBio Announces Expo Tours; Extends Deadline for Innovator Showcase Applications
5. FDA Accepts ISO-Vorin(TM) New Drug Application Amendment Submitted by Spectrum Pharmaceuticals
6. Isis Announces $4.2 Million in Government Contracts Awarded to Its Ibis Subsidiary for Biodefense Applications Development
7. Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia
8. Nitecs IND Application for Clinical Development With Lodotra Accepted by the FDA
9. CV Therapeutics Submits Supplemental New Drug Application for Ranexa(R) (ranolazine extended-release tablets)
10. National Stem Cell Holding Announces Patent Application for Newly Discovered Cellular Derived Biomaterials for Anti-Aging Applications
11. Laser Energetics to Integrate BrightStar(TM) Alexandrite Lasers in Medical and Dental Applications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... 2015   Sigma-Aldrich Corporation (NASDAQ: SIAL ... announced today it has entered into an agreement ... engineered human neural differentiated cells and accompanying culture ... diseases. These new products, in combination with Sigma-Aldrich,s ... for the study of central nervous system (CNS) ...
(Date:6/2/2015)... 2, 2015 GOJO, inventors of PURELL ® ... antibiotic stewardship at the White House Forum.  GOJO was ... organizations and stakeholders at the White House Forum to ... the emergence of antibiotic-resistant bacteria, detect resistant strains, preserve ... spread of resistant infections. "A primary prevention ...
(Date:6/2/2015)... 2015 GenoCAD , a platform ... protein expression, announced the formation of its new board ... entrepreneurs with a broad range of experience in the ... team includes: , Jimmy Roussel, Entrepreneur in Residence at ... background in technology and marketing. He has served in ...
(Date:6/1/2015)... Korea , June 1, 2015 This ... (GCBT) kicked off construction today on its biopharmaceutical facility ... Campus. The CA$315 million project represents one of the ... in the biopharmaceutical industry, giving place to ... albumin manufacturing plant in Canada . ...
Breaking Biology Technology:Sigma-Aldrich to Launch XCell Science Genetically Engineered iPSC-Derived Neural Disease Cells 2Sigma-Aldrich to Launch XCell Science Genetically Engineered iPSC-Derived Neural Disease Cells 3GOJO Among Leaders At The White House Forum On Antibiotic Stewardship 2GOJO Among Leaders At The White House Forum On Antibiotic Stewardship 3GOJO Among Leaders At The White House Forum On Antibiotic Stewardship 4GenoCAD Announces New Board of Advisors, Improves Protein Expression Using Custom Gene Synthesis 2GenoCAD Announces New Board of Advisors, Improves Protein Expression Using Custom Gene Synthesis 3Green Cross Biotherapeutics Kicks Off Construction in Montreal 2Green Cross Biotherapeutics Kicks Off Construction in Montreal 3
... Campaign for Cancer Prevention (CCP) began in 2007 with the ... about preventing cancer.  It has now grown to a more ... the social media platform, Causes.com. Nearly five years later, CCP ... a Harvard Medical School flagship teaching hospital, with all campaign ...
... 2011 Redwood Bioscience, a biopharmaceutical company developing ... conjugates, announced the appointment of Peter Van Vlasselaer, ... Directors.  In this role, Dr. Van Vlasselaer will ... development as well as corporate strategy.  Dr. Van ...
... LAGUNA NIGUEL, Calif., Oct. 3, 2011 Inspiration Biopharmaceuticals, ... (EMA) has validated and accepted the filing of the ... factor IX (FIX) product for the treatment and prevention ... so, the EMA has verified that it will begin ...
Cached Biology Technology:Campaign for Cancer Prevention Connects 6 Million+ Members on Facebook Causes to Groundbreaking Research at Brigham and Women's Hospital 2Campaign for Cancer Prevention Connects 6 Million+ Members on Facebook Causes to Groundbreaking Research at Brigham and Women's Hospital 3Campaign for Cancer Prevention Connects 6 Million+ Members on Facebook Causes to Groundbreaking Research at Brigham and Women's Hospital 4Redwood Bioscience Appoints Peter Van Vlasselaer, PhD as Executive Chairman 2Inspiration Biopharmaceuticals Announces Acceptance of European Marketing Authorization Application for IB1001 for the Treatment of Hemophilia B 2Inspiration Biopharmaceuticals Announces Acceptance of European Marketing Authorization Application for IB1001 for the Treatment of Hemophilia B 3
(Date:5/29/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/2w6zgs/facial ) has ... Market by Solution, by Software, by Hardware, by ... report to their offering. The last ... more efficient and cost effective. This has helped ... the commercial sector. The development of 3D facial ...
(Date:5/26/2015)... Research and Markets ( ... "Saudi Arabia Biometric Systems Market Forecast and ... (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,The biometric systems market in ... to grow at over 22% CAGR through 2020 ... the surging demand for better biometric technologies in ...
(Date:5/22/2015)... According to a new market research report ... by Software (Middleware, Databases), by Hardware (Cameras, Integrated Devices), ... - Global Forecast to 2020", published by MarketsandMarkets, Facial ... to $6.19 Billion by 2020, at a CAGR of ... and   43 Figures spread through 140 Pages and ...
Breaking Biology News(10 mins):Global advanced Facial Recognition Market Expected to Grow From $2.77 Billion in 2015 to $6.19 Billion in 2020, at an Estimated CAGR of 17.4% 2Saudi Arabia Biometric Systems Market Forecast and Opportunities, 2020 with Morpho Safran, ZK Technlogy, and Suprema Dominating 2Facial Recognition Market Worth $6.19 Billion by 2020 2Facial Recognition Market Worth $6.19 Billion by 2020 3
... healthy diets through adolescence than their peers who do not drink ... study showed that girls who drank soda at age five had ... duration of the study, which ended at age 15. Girls who ... nutritional requirements, but their diets were healthier. The difference between ...
... The WHO Fracture Risk Assessment Tool (FRAX) is now easily ... access and easy to use in any clinical setting. ... year probability of a major osteoporotic event, The 10 year ... users, NOGG guidance is accessible. This provides a guide for ...
... WASHINGTON, DC A new analysis by the ... that the U.S. government has spent around $430 million ... the Department of Energy funding a majority of the ... European Union and three individual European countries the ...
Cached Biology News:Early consumption of soda indicator of unhealthy diet 2Early consumption of soda indicator of unhealthy diet 3
This Dedicated 18" X 18" (45.7 X 45.7 cm.) shaker platforms are optimized for a particular flask clip size. Dedicated platforms come fully loaded with flask clips....
... The VARIOKLAV 75 S and 135 S ... their double bottoms combine the advantages of a ... for use, effective deaeration and drying by built-in ... device - fast cooling. The chamber is free ...
... Forma Refrigerated Console Orbital Shakers combine ... ergonomics, unequalled programming power. The ... allowing the unit to run with ... HEPA filtration system reduces contamination. ...
... 4300 System features Saga GT , is ... automates electrophoresis, lane finding, location of standards, ... ,Saga GT is second generation software ... initially developed at the University of Washington ...
Biology Products: